1172 related articles for article (PubMed ID: 26043152)
21. Assessment of aortic annulus dimensions for Edwards SAPIEN Transapical Heart Valve implantation by computed tomography: calculating average diameter using a virtual ring method.
Blanke P; Siepe M; Reinöhl J; Zehender M; Beyersdorf F; Schlensak C; Langer M; Pache G
Eur J Cardiothorac Surg; 2010 Dec; 38(6):750-8. PubMed ID: 20472458
[TBL] [Abstract][Full Text] [Related]
22. Initial Single-Center Experience With the Fully Repositionable Transfemoral Lotus Aortic Valve System.
Jarr KU; Leuschner F; Meder B; Katus HA; Bekeredjian R; Chorianopoulos E
J Invasive Cardiol; 2017 Jan; 29(1):30-35. PubMed ID: 27845874
[TBL] [Abstract][Full Text] [Related]
23. Comparison of transcatheter aortic valve implantation with the newest-generation Sapien 3 vs. Direct Flow Medical valve in a single center cohort.
Schulz E; Jabs A; Tamm A; Herz P; Schulz A; Gori T; von Bardeleben S; Kasper-König W; Hink U; Vahl CF; Münzel T
Int J Cardiol; 2017 Apr; 232():186-191. PubMed ID: 28089455
[TBL] [Abstract][Full Text] [Related]
24. Aortic regurgitation after transcatheter aortic valve implantation with balloon- and self-expandable prostheses: a pooled analysis from a 2-center experience.
Abdel-Wahab M; Comberg T; Büttner HJ; El-Mawardy M; Chatani K; Gick M; Geist V; Richardt G; Neumann FJ;
JACC Cardiovasc Interv; 2014 Mar; 7(3):284-92. PubMed ID: 24650401
[TBL] [Abstract][Full Text] [Related]
25. Procedural and 30-day clinical outcomes following transcatheter aortic valve replacement with lotus valve: Results of the RELEVANT study.
Montone RA; Testa L; Fraccaro C; Montorfano M; Castriota F; Nerla R; Angelillis M; Tusa M; Giannini F; Garatti A; Tarantini G; Petronio AS; Brambilla N; Bedogni F
Catheter Cardiovasc Interv; 2017 Dec; 90(7):1206-1211. PubMed ID: 28145039
[TBL] [Abstract][Full Text] [Related]
26. Direct transfemoral transcatheter aortic valve implantation without balloon pre-dilatation using the Edwards Sapien XT valve.
Bandali A; Parry-Williams G; Kassam A; Palmer S; Williams PD; de Belder MA; Owens A; Goodwin A; Muir DF
Catheter Cardiovasc Interv; 2016 Nov; 88(6):978-985. PubMed ID: 27189391
[TBL] [Abstract][Full Text] [Related]
27. Device landing zone calcification and its impact on residual regurgitation after transcatheter aortic valve implantation with different devices.
Seiffert M; Fujita B; Avanesov M; Lunau C; Schön G; Conradi L; Prashovikj E; Scholtz S; Börgermann J; Scholtz W; Schäfer U; Lund G; Ensminger S; Treede H
Eur Heart J Cardiovasc Imaging; 2016 May; 17(5):576-84. PubMed ID: 26160399
[TBL] [Abstract][Full Text] [Related]
28. Transfemoral TAVI without pre-dilatation using balloon-expandable devices: a case-matched analysis.
Conradi L; Schaefer A; Seiffert M; Schirmer J; Schaefer U; Schön G; Blankenberg S; Reichenspurner H; Treede H; Diemert P
Clin Res Cardiol; 2015 Sep; 104(9):735-42. PubMed ID: 25725778
[TBL] [Abstract][Full Text] [Related]
29. Feasibility and safety of transfemoral implantation of Edwards SAPIEN XT prosthesis without balloon valvuloplasty in severe stenosis of native aortic valve.
García E; Martín P; Hernández R; Rodríguez V; Fernández A; Gama V; Almería C; Macaya C
Catheter Cardiovasc Interv; 2014 Apr; 83(5):791-5. PubMed ID: 24285561
[TBL] [Abstract][Full Text] [Related]
30. First experience with the new generation Edwards Sapien 3 aortic bioprosthesis: procedural results and short term outcome.
Murray MI; Geis N; Pleger ST; Kallenbach K; Katus HA; Bekeredjian R; Chorianopoulos E
J Interv Cardiol; 2015 Feb; 28(1):109-16. PubMed ID: 25689554
[TBL] [Abstract][Full Text] [Related]
31. European experience with the second-generation Edwards SAPIEN XT transcatheter heart valve in patients with severe aortic stenosis: 1-year outcomes from the SOURCE XT Registry.
Schymik G; Lefèvre T; Bartorelli AL; Rubino P; Treede H; Walther T; Baumgartner H; Windecker S; Wendler O; Urban P; Mandinov L; Thomas M; Vahanian A
JACC Cardiovasc Interv; 2015 Apr; 8(5):657-69. PubMed ID: 25946437
[TBL] [Abstract][Full Text] [Related]
32. Feasibility and safety of early discharge after transfemoral transcatheter aortic valve implantation with the Edwards SAPIEN-XT prosthesis.
Durand E; Eltchaninoff H; Canville A; Bouhzam N; Godin M; Tron C; Rodriguez C; Litzler PY; Bauer F; Cribier A
Am J Cardiol; 2015 Apr; 115(8):1116-22. PubMed ID: 25726383
[TBL] [Abstract][Full Text] [Related]
33. Prospective analysis of 30-day safety and performance of transfemoral transcatheter aortic valve implantation with Edwards SAPIEN XT versus SAPIEN prostheses.
Eltchaninoff H; Durand E; Borz B; Godin M; Tron C; Litzler PY; Bessou JP; Bejar K; Fraccaro C; Sanchez-Giron C; Dacher JN; Bauer F; Cribier A
Arch Cardiovasc Dis; 2012 Mar; 105(3):132-40. PubMed ID: 22520795
[TBL] [Abstract][Full Text] [Related]
34. First-in-man transfemoral transcatheter aortic valve replacement with the 29 mm Edwards SAPIEN XT valve.
Freeman M; Rodés-Cabau J; Urena M; DeLarochelliere R; Dumont E; Masson JB; Willson AB; Binder RK; Toggweiler S; Leipsic J; Wood DA; Webb JG
Catheter Cardiovasc Interv; 2013 Oct; 82(4):664-70. PubMed ID: 22744829
[TBL] [Abstract][Full Text] [Related]
35. Predictors of Paravalvular Regurgitation After Implantation of the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Valve (from the REPRISE II Trial Extended Cohort).
Blackman DJ; Meredith IT; Dumonteil N; Tchétché D; Hildick-Smith D; Spence MS; Walters DL; Harnek J; Worthley SG; Rioufol G; Lefèvre T; Houle VM; Allocco DJ; Dawkins KD
Am J Cardiol; 2017 Jul; 120(2):292-299. PubMed ID: 28535962
[TBL] [Abstract][Full Text] [Related]
36. First experience with transfemoral transcatheter aortic valve implantation without prior balloon pre-dilatation using a latest generation repositionable and retrievable transcatheter heart valve†.
Schaefer A; Harmel E; Seiffert M; Reichart D; Deuschl F; Schofer N; Schneeberger Y; Blankenberg S; Reichenspurner H; Schaefer U; Conradi L
Interact Cardiovasc Thorac Surg; 2017 May; 24(5):659-662. PubMed ID: 28329312
[TBL] [Abstract][Full Text] [Related]
37. Transcatheter aortic valve implantation with the Edwards SAPIEN versus the Medtronic CoreValve Revalving system devices: a multicenter collaborative study: the PRAGMATIC Plus Initiative (Pooled-RotterdAm-Milano-Toulouse In Collaboration).
Chieffo A; Buchanan GL; Van Mieghem NM; Tchetche D; Dumonteil N; Latib A; van der Boon RM; Vahdat O; Marcheix B; Farah B; Serruys PW; Fajadet J; Carrié D; de Jaegere PP; Colombo A
J Am Coll Cardiol; 2013 Feb; 61(8):830-6. PubMed ID: 23333140
[TBL] [Abstract][Full Text] [Related]
38. Procedural results and 30-day clinical events analysis following Edwards transcatheter aortic valve implantation in 48 consecutive patients: initial experience.
Zhao QM; Lognone T; Ivascau C; Sabatier R; Roule V; Dahdouh Z; Massetti M; Grollier G
Chin Med J (Engl); 2012 Aug; 125(16):2807-10. PubMed ID: 22932071
[TBL] [Abstract][Full Text] [Related]
39. Early and mid-term outcomes of 1904 patients undergoing transcatheter balloon-expandable valve implantation in Italy: results from the Italian Transcatheter Balloon-Expandable Valve Implantation Registry (ITER).
Salizzoni S; D'Onofrio A; Agrifoglio M; Colombo A; Chieffo A; Cioni M; Besola L; Regesta T; Rapetto F; Tarantini G; Napodano M; Gabbieri D; Saia F; Tamburino C; Ribichini F; Cugola D; Aiello M; Sanna F; Iadanza A; Pompei E; Stefàno P; Cappai A; Minati A; Cassese M; Martinelli GL; Agostinelli A; Fiorilli R; Casilli F; Reale M; Bedogni F; Petronio AS; Mozzillo RA; Bonmassari R; Briguori C; Liso A; Sardella G; Bruschi G; Fiorina C; Filippini C; Moretti C; D'Amico M; La Torre M; Conrotto F; Di Bartolomeo R; Gerosa G; Rinaldi M;
Eur J Cardiothorac Surg; 2016 Dec; 50(6):1139-1148. PubMed ID: 27406375
[TBL] [Abstract][Full Text] [Related]
40. Clinical outcomes of self-expandable vs. balloon-expandable TAVI for severe aortic stenosis.
Tham JLM; Adams H; Paleri S; Wright C; Dimitriou J; Newcomb A; MacIsaac AI; Whitbourn RJ; Palmer SC
Acta Cardiol; 2020 Jun; 75(3):218-225. PubMed ID: 30931804
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
